Merck & Co., Inc. (LON:0QAH)
London · Delayed Price · Currency is GBP · Price in USD 84.95
+0.92 (1.10%)
At close: Jul 25, 2025
Merck & Co. Market Cap
Merck & Co. has a market cap or net worth of 158.29 billion as of July 25, 2025. Its market cap has decreased by -36.94% in one year.
Market Cap
158.29B
Enterprise Value
177.41B
Revenue
49.47B
Ranking
n/a
PE Ratio
11.73
Stock Price
84.95
Market Cap Chart
Since January 2, 1968, Merck & Co.'s market cap has increased from 3.01B to 158.29B, an increase of 5,166.38%. That is a compound annual growth rate of 7.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 158.29B | -21.25% |
| Dec 31, 2024 | 201.01B | -7.32% |
| Dec 29, 2023 | 216.89B | -7.10% |
| Dec 30, 2022 | 233.47B | 63.30% |
| Dec 31, 2021 | 142.97B | -5.68% |
| Dec 31, 2020 | 151.58B | -13.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.50B |
| GSK plc | 56.21B |
| Haleon | 32.84B |
| Smith & Nephew | 10.27B |
| ConvaTec Group | 4.90B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.28B |
| Oxford Nanopore Technologies | 2.02B |